Chest Medicine
Review: Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID‐19
13 Oct, 2020 | 01:12h | UTC
[Preprint] Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
13 Oct, 2020 | 01:08h | UTC
Commentary on Twitter
Anyone think we prescribe too many #antibiotics in #COVID19?
Looking for ways to prescribe less?
Well, our latest *PREPRINT* (not peer reviewed!) may be of interest. #antibioticstewardship https://t.co/qUimnZhwg7 Thread (1/7) pic.twitter.com/Z6gaGMgduv— Gabriele Pollara (@gpollara) October 12, 2020
Study: Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
13 Oct, 2020 | 01:10h | UTC
Commentary on Twitter
👨⚕️ Researchers from @HKUniversity test a set of metallodrugs and related compounds, and identify ranitidine bismuth citrate, a commonly used drug for the treatment of Helicobacter pylori #infection, as a potent anti-#SARS-CoV-2 agent.
👁️ Full article https://t.co/Oz5O7hL9js pic.twitter.com/izMRdRTT27
— Immunology of Infectious Disease News (@infdisease_news) October 12, 2020
‘Long Covid’: Why are some people not recovering?
13 Oct, 2020 | 01:03h | UTC‘Long Covid’: Why are some people not recovering? – BBC
Meta-analysis: ECMO for severe ARDS
13 Oct, 2020 | 00:58h | UTC
Commentary on Twitter
#ECMO vs conventional strategies in severe #ARDS, meta-analysis of individual patient data:#ECMO-group pts spent more days alive out of the #ICU & without respiratory, cardiovascular, renal, neurological failure. Open access @yourICM #FOAMcc #FOAMecmo https://t.co/3PV2gAHA3G https://t.co/k6MQYUjKgu
— Intensive Care Medicine (@yourICM) October 7, 2020
Review: Characteristics of SARS-CoV-2 and COVID-19
12 Oct, 2020 | 00:49h | UTCCharacteristics of SARS-CoV-2 and COVID-19 – Nature Reviews Microbiology
Commentary on Twitter
Characteristics of SARS-CoV-2 and COVID-19
Zheng-Li Shi et al. summarize the exceptional amount of research that has characterized SARS-CoV-2 and COVID-19, discussing the emergence and virology of SARS-CoV-2 and the pathogenesis and treatment of COVID-19https://t.co/kGL6nOdOYu pic.twitter.com/1ePqHvLxFz
— Nature Reviews Microbiology (@NatureRevMicro) October 6, 2020
Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset
12 Oct, 2020 | 00:44h | UTCCommentary: Even Mild Covid-19 Infections Can Make People Sick for Months – Bloomberg
Commentary on Twitter
Follow-up of adults with non-critical COVID-19 two months after symptoms' onset – Clinical Microbiology and Infection Two thirds of adults with non-critical COVID-19 had persistent symptoms up to 2 months after symptom onset. https://t.co/xZk2DURyTG
— Carlos del Rio (@CarlosdelRio7) October 10, 2020
Esophageal emergencies: Another important cause of acute chest pain
12 Oct, 2020 | 00:30h | UTCEsophageal emergencies: another important cause of acute chest pain – Insights into Imaging
RECOVERY trial: Effect of hydroxychloroquine in hospitalized patients with Covid-19
9 Oct, 2020 | 09:15h | UTC
Remdesivir for the treatment of Covid-19 — final report
9 Oct, 2020 | 09:13h | UTCRemdesivir for the Treatment of Covid-19 — Final Report – New England Journal of Medicine
Commentary: BREAKING NEWS: Final remdesivir results published after 139 days of waiting – Brief19
Commentary on Twitter
📍Remdesivir trial (ACTT-1) final results finally out.
📍Still no mortality benefit. A study with tons of patients could show some small mortality benefit.
📍Those who recover, do so a bit faster.
📍Not the game-changer that was hyped.via @Brief_19https://t.co/jWRJypJIuS
— Jeremy Faust MD MS (ER physician) (@jeremyfaust) October 8, 2020
[News release – not published yet] Eli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19
9 Oct, 2020 | 09:09h | UTCEli Lilly says its monoclonal antibody cocktail is effective in treating Covid-19 – STAT
Comparison of chest radiograph interpretations by artificial intelligence algorithm vs. radiology residents
12 Oct, 2020 | 00:27h | UTC
Commentary on Twitter
Diagnostic study finds an #AI algorithm has similar sensitivity with improved specificity and positive predictive value vs radiology residents when reading AP chest x-rays. https://t.co/SBUaZTz6OC
— JAMA Network Open (@JAMANetworkOpen) October 10, 2020
Non-invasive positive pressure ventilation in patients with COVID-19
9 Oct, 2020 | 08:58h | UTCNon-Invasive Positive Pressure Ventilation in Patients With COVID-19 – Mayo Clinic Proceedings
Systematic review: Not enough evidence to recommend vena caval filters for the prevention of pulmonary embolism
9 Oct, 2020 | 08:52h | UTCVena caval filters for the prevention of pulmonary embolism – Cochrane Library
Summary: Vena caval filters for the prevention of pulmonary embolism – Cochrane Library
Editorial: The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
8 Oct, 2020 | 09:15h | UTC
ATS/ERS Updated guidance on the management of COVID-19
8 Oct, 2020 | 09:16h | UTC
What is post-viral fatigue syndrome, the condition affecting some COVID-19 survivors?
8 Oct, 2020 | 09:08h | UTC
5 things to know about a COVID vaccine: It won’t be a ‘magic wand’
8 Oct, 2020 | 09:05h | UTC5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’ – Kaiser Health News
How the leading coronavirus vaccines work
8 Oct, 2020 | 09:06h | UTCHow the leading coronavirus vaccines work – The Conversation
Related: SARS-CoV-2 Vaccine Development: Current Status – Mayo Clinic Proceedings
Randomized trial: Lopinavir–ritonavir not beneficial for patients admitted to hospital with COVID-19
7 Oct, 2020 | 08:50h | UTCCommentaries: Study: HIV drug of no benefit to hospitalized COVID patients – CIDRAP AND Antiviral monotherapy for hospitalised patients with COVID-19 is not enough – The Lancet AND
Commentary on Twitter
NEW—Lopinavir-ritonavir is not an effective treatment for patients hospitalised with #COVID19: finding from RECOVERY, randomised, controlled, open-label, platform trial https://t.co/RpiUAvWF1I pic.twitter.com/uI3yiQbEgK
— The Lancet (@TheLancet) October 6, 2020
ACP Guidance: Should Remdesivir be used for the treatment of patients with COVID-19?
7 Oct, 2020 | 09:21h | UTCSystematic review: Remdesivir for Adults With COVID-19: A Living Systematic Review for an American College of Physicians Practice Points – Annals of Internal Medicine
Flurry of coronavirus reinfections leaves scientists puzzled
7 Oct, 2020 | 09:15h | UTCFlurry of coronavirus reinfections leaves scientists puzzled – The Guardian
Face masks: what the data say
7 Oct, 2020 | 09:17h | UTCFace masks: what the data say – Nature
Commentary on Twitter
#Facemasks: what the data say.#Masks work, but they are not infallible.
You decrease your risk of contagion if you wear them properly AND apply other #hygiene measures, keep your physical distance, and ventilate indoor spaces well.#covid #covid19
https://t.co/uNqehIC2pF— Vanessa Campo-Ruiz, MD PhD (@VCSTX) October 6, 2020
Covid-19: Risk of death more than doubled in people who also had flu, English data show
7 Oct, 2020 | 09:11h | UTCCovid-19: Risk of death more than doubled in people who also had flu, English data show – The BMJ
Original study (preprint): Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design – medRxiv
Commentary on Twitter
People infected with both flu and SARS-CoV-2 are more than twice as likely to die as someone with the new coronavirus alone, emerging evidence analysed by @PHE_uk has found. The data has been published as a preprint on medRxivhttps://t.co/3Qv3gxGRXB
— The BMJ (@bmj_latest) September 23, 2020
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19
7 Oct, 2020 | 09:07h | UTCThoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
Commentaries: How accurate is chest imaging for diagnosing COVID-19? – Cochrane Library AND Featured Review: Thoracic imaging tests for the diagnosis of COVID-19 – Cochrane Library